A novel strategy for treatment of bladder cancer: Antibody-drug conjugates.
Journal Information
Full Title: Investig Clin Urol
Abbreviation: Investig Clin Urol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICTS OF INTEREST: The authors have nothing to disclose."
Funding Disclosure
Evidence found in paper:
"FUNDING: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Republic of Korea (NRF-2021R1A2C1004307 and NRF-2021M3E5E6037643)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025